BACKGROUND. After a pancreatic endocrine tumor has been diagnosed on the basis of clinical signs and the results of laboratory tests, localization of the tumor by the usual imaging procedures fails in as many as 40 to 60 percent of patients. Endoscopic ultrasonography, a sensitive test for small carcinomas of the pancreas, might also be useful in patients with endocrine tumors of the pancreas that cannot be localized by conventional methods. METHODS. We studied 37 patients later shown to have 39 endocrine tumors of the pancreas who had negative results on transabdominal ultrasonography and CT. All the patients underwent endoscopic ultrasonography, and 22 also underwent selective angiography. All the tumors were confirmed by surgical excision and immunohistologic examination; they consisted of 31 insulinomas, 7 gastrinomas, and 1 glucagonoma, 0.5 to 2.5 cm (mean, 1.4 cm) in diameter. All but one of the patients were cured of their disease, as ascertained by at least six months of clinical and laboratory follow-up. RESULTS. Using endoscopic ultrasonography, we were able to localize 32 of the 39 tumors (sensitivity, 82 percent); no tumor was incorrectly localized. The size of the tumors was very similar (within 2 mm) to that predicted by endoscopic ultrasonography. Among the 22 patients who underwent both angiography and endoscopic ultrasonography, ultrasonography was significantly more sensitive than angiography for tumor localization (sensitivity, 82 percent vs. 27 percent). Among 19 control patients without pancreatic endocrine tumors, endoscopic ultrasonography was negative in 18 (specificity, 95 percent). CONCLUSIONS. Endoscopic ultrasonography is a highly sensitive and specific procedure for the localization of pancreatic endocrine tumors. It should be considered for the preoperative localization of such tumors once the clinical and laboratory diagnosis has been established.
Source Information
Department of Internal Medicine II, Technical University of Munich, Germany.
This article has been cited by other articles:
Guettier, J.-M., Kam, A., Chang, R., Skarulis, M. C., Cochran, C., Alexander, H. R., Libutti, S. K., Pingpank, J. F., Gorden, P.
(2009). Localization of Insulinomas to Regions of the Pancreas by Intraarterial Calcium Stimulation: The NIH Experience. J. Clin. Endocrinol. Metab.
94: 1074-1080
[Abstract][Full Text]
Jager, P. L., Chirakal, R., Marriott, C. J., Brouwers, A. H., Koopmans, K. P., Gulenchyn, K. Y.
(2008). 6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications. JNM
49: 573-586
[Abstract][Full Text]
Marney, A., Jagasia, S.
(2007). Diagnostic Dilemma in a Patient With Insulinoma. Clin. Diabetes
25: 152-154
[Full Text]
Kazanjian, K. K., Reber, H. A., Hines, O. J.
(2006). Resection of Pancreatic Neuroendocrine Tumors: Results of 70 Cases. Arch Surg
141: 765-770
[Abstract][Full Text]
Pancreatic Section,
(2005). Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut
54: v1-v16
[Full Text]
Liang, K. P., Mueller, P. S.
(2005). 68-Year-Old Man With Chronic Diarrhea, Nausea, and Vomiting. Mayo Clin Proc.
80: 533-536
Mittendorf, E. A., Liu, Y.-C., McHenry, C. R.
(2005). Giant Insulinoma: Case Report and Review of the Literature. J. Clin. Endocrinol. Metab.
90: 575-580
[Abstract][Full Text]
Manoharan, P, Sheridan, M B
(2004). Neoplasms of the pancreas. Imaging
16: 323-337
[Abstract][Full Text]
Kaltsas, G. A., Besser, G. M., Grossman, A. B.
(2004). The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. Endocr. Rev.
25: 458-511
[Abstract][Full Text]
Jaroszewski, D. E., Schlinkert, R. T., Thompson, G. B., Schlinkert, D. K.
(2004). Laparoscopic Localization and Resection of Insulinomas. Arch Surg
139: 270-274
[Abstract][Full Text]
Gouya, H., Vignaux, O., Augui, J., Dousset, B., Palazzo, L., Louvel, A., Chaussade, S., Legmann, P.
(2003). CT, Endoscopic Sonography, and a Combined Protocol for Preoperative Evaluation of Pancreatic Insulinomas. Am. J. Roentgenol.
181: 987-992
[Abstract][Full Text]
Fidler, J. L., Fletcher, J. G., Reading, C. C., Andrews, J. C., Thompson, G. B., Grant, C. S., Service, F. J.
(2003). Preoperative Detection of Pancreatic Insulinomas on Multiphasic Helical CT. Am. J. Roentgenol.
181: 775-780
[Abstract][Full Text]
Power, N, Reznek, R H
(2002). Imaging pancreatic islet cell tumours. Imaging
14: 147-159
[Abstract][Full Text]
Kwekkeboom, D., Krenning, E. P., de Jong, M.
(2000). Peptide Receptor Imaging and Therapy. JNM
41: 1704-1713
[Abstract][Full Text]
Brandt, L. J., Mark, E. J.
(2000). Case 4-2000- A 64-Year-Old Man with Cushing's Syndrome and a Pancreatic Mass. NEJM
342: 414-420
[Full Text]
Brugge, W. R., Dam, J. V.
(1999). Pancreatic and Biliary Endoscopy. NEJM
341: 1808-1816
[Full Text]
Lo, C.-Y., Lam, K.-Y., Kung, A. W. C., Lam, K. S. L., Tung, P. H. M., Fan, S.-T.
(1997). Pancreatic Insulinomas: A 15-Year Experience. Arch Surg
132: 926-930
[Abstract]
Zimmer, T., Stolzel, U., Bader, M., Fett, U., Foss, H.-D., Riecken, E.-O., Rehfeld, J. F., Wiedenmann, B.
(1995). A Duodenal Gastrinoma in a Patient with Diarrhea and Normal Serum Gastrin Concentrations. NEJM
333: 634-637
[Full Text]
Debas, H. T., Mulvihill, S. J.
(1994). Neuroendocrine Gut Neoplasms: Important Lessons From Uncommon Tumors. Arch Surg
129: 965-972
[Abstract]
Jensen, R. T., Fraker, D. L.
(1994). Zollinger-Ellison Syndrome: Advances in Treatment of Gastric Hypersecretion and the Gastrinoma. JAMA
271: 1429-1435
[Abstract]
